FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomasChristopher I. Milton(Institute of Cancer Research), Janet Shipley(Institute of Cancer Research)Molecular OncologyNovember 30, 202110.1002/1878-0261.13145Cited by 18SaveCiteExport RISWatch citationsRelated PapersJARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells|Oncogene|2013|105IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance|The Journal of Pathology|2017|29The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells|BMC Cancer|2018|28